Biopharmaceutical CMO Market Size, Share & Industry Analysis, By Service (Manufacturing {Upstream Processing and Downstream Processing}, Fill & Finish Operations, Analytical & QC Studies, and Packaging), By Source (Mammalian and Non-Mammalian), By Product (Biologics and Biosimilars), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI103346

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Technological Advancements in Biopharmaceutical CMO
2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
3. Overview: Regulatory Scenario, By Key Countries/Regions
4. Impact of COVID 19 on the Market
Global Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Thermo Fisher Scientific Inc.
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Wuxi Biologics
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Lonza
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Recipharm AB
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Catalent Inc.
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. FUJIFILM Corporation (FUJIFILM Diosynth Biotechnologies)
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Cambrex Corporation
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Samsung Biologics
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Siegfried Holding AG
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Technological Advancements in Biopharmaceutical CMO
2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
3. Overview: Regulatory Scenario, By Key Countries/Regions
4. Impact of COVID 19 on the Market
Global Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Biopharmaceutical CMO Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Service
  1. Manufacturing
    1. Upstream Processing
    2. Downstream Processing
  2. Fill & Finish Operations
  3. Analytical & QC Studies
  4. Packaging
2. Market Analysis, Insights and Forecast – By Source
  1. Mammalian
  2. Non-Mammalian
3. Market Analysis, Insights and Forecast – By Product
  1. Biologics
  2. Biosimilars
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Thermo Fisher Scientific Inc.
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Wuxi Biologics
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Lonza
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Recipharm AB
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Catalent Inc.
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. FUJIFILM Corporation (FUJIFILM Diosynth Biotechnologies)
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Cambrex Corporation
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Samsung Biologics
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Siegfried Holding AG
    1. Overview
    2. Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Biopharmaceutical CMO Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Biopharmaceutical CMO Market Value Share (%), by Service, 2025 & 2034

Figure 3: Global Biopharmaceutical CMO Market Value Share (%), by Source, 2025 & 2034

Figure 4: Global Biopharmaceutical CMO Market Value Share (%), by Product, 2025 & 2034

Figure 5: Global Biopharmaceutical CMO Market Value (USD billion), by Region, 2025 & 2034

Figure 6: North America Biopharmaceutical CMO Market Value (USD billion), by Service, 2025 & 2034

Figure 7: North America Biopharmaceutical CMO Market Value Share (%), by Service, 2025

Figure 8: North America Biopharmaceutical CMO Market Value (USD billion), by Source, 2025 & 2034

Figure 9: North America Biopharmaceutical CMO Market Value Share (%), by Source, 2025

Figure 10: North America Biopharmaceutical CMO Market Value (USD billion), by Product, 2025 & 2034

Figure 11: North America Biopharmaceutical CMO Market Value Share (%), by Product, 2025

Figure 12: North America Biopharmaceutical CMO Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Biopharmaceutical CMO Market Value Share (%), By Country, 2025

Figure 14: Europe Biopharmaceutical CMO Market Value (USD billion), by Service, 2025 & 2034

Figure 15: Europe Biopharmaceutical CMO Market Value Share (%), by Service, 2025

Figure 16: Europe Biopharmaceutical CMO Market Value (USD billion), by Source, 2025 & 2034

Figure 17: Europe Biopharmaceutical CMO Market Value Share (%), by Source, 2025

Figure 18: Europe Biopharmaceutical CMO Market Value (USD billion), by Product, 2025 & 2034

Figure 19: Europe Biopharmaceutical CMO Market Value Share (%), by Product, 2025

Figure 20: Europe Biopharmaceutical CMO Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 21: Europe Biopharmaceutical CMO Market Value Share (%), By Country/ Sub-region, 2025

Figure 22: Asia Pacific Biopharmaceutical CMO Market Value (USD billion), by Service, 2025 & 2034

Figure 23: Asia Pacific Biopharmaceutical CMO Market Value Share (%), by Service, 2025

Figure 24: Asia Pacific Biopharmaceutical CMO Market Value (USD billion), by Source, 2025 & 2034

Figure 25: Asia Pacific Biopharmaceutical CMO Market Value Share (%), by Source, 2025

Figure 26: Asia Pacific Biopharmaceutical CMO Market Value (USD billion), by Product, 2025 & 2034

Figure 27: Asia Pacific Biopharmaceutical CMO Market Value Share (%), by Product, 2025

Figure 28: Asia Pacific Biopharmaceutical CMO Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 29: Asia Pacific Biopharmaceutical CMO Market Value Share (%), By Country/ Sub-region, 2025

Figure 30: Latin America Biopharmaceutical CMO Market Value (USD billion), by Service, 2025 & 2034

Figure 31: Latin America Biopharmaceutical CMO Market Value Share (%), by Service, 2025

Figure 32: Latin America Biopharmaceutical CMO Market Value (USD billion), by Source, 2025 & 2034

Figure 33: Latin America Biopharmaceutical CMO Market Value Share (%), by Source, 2025

Figure 34: Latin America Biopharmaceutical CMO Market Value (USD billion), by Product, 2025 & 2034

Figure 35: Latin America Biopharmaceutical CMO Market Value Share (%), by Product, 2025

Figure 36: Latin America Biopharmaceutical CMO Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 37: Latin America Biopharmaceutical CMO Market Value Share (%), By Country/ Sub-region, 2025

Figure 38: Middle East & Africa Biopharmaceutical CMO Market Value (USD billion), by Service, 2025 & 2034

Figure 39: Middle East & Africa Biopharmaceutical CMO Market Value Share (%), by Service, 2025

Figure 40: Middle East & Africa Biopharmaceutical CMO Market Value (USD billion), by Source, 2025 & 2034

Figure 41: Middle East & Africa Biopharmaceutical CMO Market Value Share (%), by Source, 2025

Figure 42: Middle East & Africa Biopharmaceutical CMO Market Value (USD billion), by Product, 2025 & 2034

Figure 43: Middle East & Africa Biopharmaceutical CMO Market Value Share (%), by Product, 2025

Figure 44: Middle East & Africa Biopharmaceutical CMO Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 45: Middle East & Africa Biopharmaceutical CMO Market Value Share (%), By Country/ Sub-region, 2025

Figure 46: Global Biopharmaceutical CMO Market Share (%), By Company, 2025

List of Tables

Table 1: Global Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Service, 2021–2034

Table 2: Global Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Manufacturing Service, 2021–2034

Table 3: Global Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Source, 2021–2034

Table 4: Global Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 5: Global Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 6: North America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Service, 2021-2034

Table 7: North America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Manufacturing Service, 2021-2034

Table 8: North America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Source, 2021-2034

Table 9: North America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 10: North America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 11: Europe Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Service, 2021-2034

Table 12: Europe Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Manufacturing Service, 2021-2034

Table 13: Europe Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Source, 2021-2034

Table 14: Europe Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 15: Europe Biopharmaceutical CMO Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 16: Asia Pacific Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Service, 2021-2034

Table 17: Asia Pacific Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Manufacturing Service, 2021-2034

Table 18: Asia Pacific Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Source, 2021-2034

Table 19: Asia Pacific Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 20: Asia Pacific Biopharmaceutical CMO Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Latin America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Service, 2021-2034

Table 22: Latin America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Manufacturing Service, 2021-2034

Table 23: Latin America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Source, 2021-2034

Table 24: Latin America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 25: Latin America Biopharmaceutical CMO Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 26: Middle East & Africa Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Service, 2021-2034

Table 27: Middle East & Africa Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Manufacturing Service, 2021-2034

Table 28: Middle East & Africa Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Source, 2021-2034

Table 29: Middle East & Africa Biopharmaceutical CMO Market Revenue (USD billion) Forecast, by Product, 2021-2034

Table 30: Middle East & Africa Biopharmaceutical CMO Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 155

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com